NCT00040183 · Interventional trial
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
Overall registry status Completed
Phase 3
Conditions Pancreatic Cancer
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
- Pennsylvania Oncology Hematology Associates · Philadelphia, PA · Philadelphia County
- University of Pennsylvania Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory